SRPT
Sarepta Therapeutics, Inc. SEC filings
Every EDGAR filing for Sarepta Therapeutics, Inc. (SRPT), newest first, with AI summaries and stories.
- Ticker
- SRPT
- CIK
- 873303
- Sector
- Biotech and pharma
- Latest filing
- Sep 23
Next: earnings expected ~Nov 4 ยท 10-Q expected ~Nov 6 (deadline Nov 9)
Filings
8-KSarepta Therapeutics, Inc.SRPTLIVE 4Sarepta Therapeutics, Inc.SRPTLIVE 4 insider filings
Ryan Ho-Yan Wong, insider filing for SRPT
Show all 4
- 4Insider filing for SRPT
- 4Insider filing for SRPT
- 4Insider filing for SRPT
- 4Insider filing for SRPT
Ryan Ho-Yan Wong, reporting
SCHEDULE 13G/ASarepta Therapeutics, Inc.SRPTLIVE Ownership stake disclosure by AQR CAPITAL MANAGEMENT LLC (amended)
AQR CAPITAL MANAGEMENT LLC, filed by
SCHEDULE 13GSarepta Therapeutics, Inc.SRPTLIVE Ownership stake disclosure by STATE STREET CORP
STATE STREET CORP, filed by
8-KSarepta Therapeutics, Inc.SRPTLIVE 10-QSarepta Therapeutics, Inc.SRPTLIVE SCHEDULE 13G/ASarepta Therapeutics, Inc.SRPTLIVE Ownership stake disclosure by VANGUARD PORTFOLIO MANAGEMENT LLC (amended)
VANGUARD PORTFOLIO MANAGEMENT LLC, filed by
SCHEDULE 13G/ASarepta Therapeutics, Inc.SRPTLIVE Ownership stake disclosure by BlackRock, Inc. (amended)
BlackRock, Inc., filed by
4Sarepta Therapeutics, Inc.SRPTLIVE 2 insider filings
Michael Severino, insider filing for SRPT
Show all 2
- 4Insider filing for SRPT
- 3New insider at SRPT
Michael Severino, reporting
S-8Sarepta Therapeutics, Inc.SRPTLIVE 8-KSarepta Therapeutics, Inc.SRPTLIVE 4Sarepta Therapeutics, Inc.SRPTLIVE 8 insider filings
Kathryn Jean Boor, insider filing for SRPT
Show all 8
- 4Insider filing for SRPT
- 4Insider filing for SRPT
- 4Insider filing for SRPT
- 4Insider filing for SRPT
- 4Insider filing for SRPT
- 4Insider filing for SRPT
- 4Insider filing for SRPT
- 4Insider filing for SRPT
Kathryn Jean Boor, reporting
S-8Sarepta Therapeutics, Inc.SRPTLIVE 8-KSarepta Therapeutics, Inc.SRPTLIVE 13F-HRSarepta Therapeutics, Inc.SRPTLIVE 8-KSarepta Therapeutics, Inc.SRPTLIVE 10-QSarepta Therapeutics, Inc.SRPTLIVE SCHEDULE 13GSarepta Therapeutics, Inc.SRPTLIVE Ownership stake disclosure by VANGUARD CAPITAL MANAGEMENT LLC
VANGUARD CAPITAL MANAGEMENT LLC, filed by
SCHEDULE 13GSarepta Therapeutics, Inc.SRPTLIVE Ownership stake disclosure by VANGUARD PORTFOLIO MANAGEMENT LLC
VANGUARD PORTFOLIO MANAGEMENT LLC, filed by
ARSSarepta Therapeutics, Inc.SRPTLIVE DEFA14ASarepta Therapeutics, Inc.SRPTLIVE DEF 14ASarepta Therapeutics, Inc.SRPTLIVE SCHEDULE 13G/ASarepta Therapeutics, Inc.SRPTLIVE Ownership stake disclosure by VANGUARD GROUP INC (amended)
VANGUARD GROUP INC, filed by
4Sarepta Therapeutics, Inc.SRPTLIVE 5 insider filings
Ian Michael Estepan, insider filing for SRPT
Show all 5
- 4Insider filing for SRPT
- 4Insider filing for SRPT
- 4Insider filing for SRPT
- 4Insider filing for SRPT
- 4Insider filing for SRPT
Ian Michael Estepan, reporting
144Sarepta Therapeutics, Inc.SRPTLIVE Stephen Mayo, planned sale of SRPT shares
Stephen Mayo, reporting
4Sarepta Therapeutics, Inc.SRPTLIVE 4 insider filings
Ryan Ho-Yan Wong, insider filing for SRPT
Show all 4
- 4Insider filing for SRPT
- 4Insider filing for SRPT
- 4Insider filing for SRPT
- 4Insider filing for SRPT
Ryan Ho-Yan Wong, reporting
4Sarepta Therapeutics, Inc.SRPTLIVE 4 insider filings
Cristin Rothfuss, insider filing for SRPT
Show all 4
- 4Insider filing for SRPT
- 4Insider filing for SRPT
- 4Insider filing for SRPT
- 4Insider filing for SRPT
Cristin Rothfuss, reporting
4Sarepta Therapeutics, Inc.SRPTLIVE Ian Michael Estepan, insider filing for SRPT
Ian Michael Estepan, reporting
10-KSarepta Therapeutics, Inc.SRPTLIVE